Work

Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints

Year: 2012

Type: article

Source: Alimentary Pharmacology & Therapeutics

DOI: 10.1111/apt.12123

Authors: E. M. M. Quigley, J. Tack, W. D. Chey, S. S. Rao, J. Fortea, M. Falques, C. Diaz, S. J. Shiff, M. G. Currie, J. M. Johnston

Institutions: University College Cork, Universitair Ziekenhuis Leuven, Michigan Medicine, Almirall (Spain), Forest Laboratories (United States), Ironwood Pharmaceuticals (United States)

Language: English

Topic: Gastrointestinal motility and disorders

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, GlaxoSmithKline, Sanofi, Procter and Gamble, Danone, Ironwood Pharmaceuticals, Incorporated, SK Life Science, Norgine

OpenAlex ID: W1968228152

FWCI: 14.28

Cites: 32

Cited by: 127

Related to: 10